SAS has announced the expansion of its portfolio with the introduction of the SAS® Clinical Acceleration Repository, a secure, cloud-native data repository built on SAS® Viya®. This innovative platform offers life sciences and healthcare organizations an open, scalable analytics solution designed to enhance productivity and accelerate innovation.
Data presents boundless opportunities for life sciences and healthcare organizations. It empowers clinical researchers to analyze and uncover trends leading to groundbreaking treatments, providing a foundation for unlocking healthcare insights more swiftly.
Streamlining Clinical Data for Innovation
The SAS Clinical Acceleration Repository addresses common challenges faced by global companies in managing clinical data and supporting clinical trial development. It offers a modular, open, cloud-native content repository for managing, reporting, sharing, and reviewing data. The platform integrates various data sources, streamlines data preparation for statistical analytics, and accelerates the path to regulatory submission.
Key benefits include:
- Unified Data Access: Provides access to curated research information and health data through a single system of record via an easy-to-use, modern user interface with intuitive dashboards.
- Production-Ready Repository: Facilitates easier and faster data validation, supports groups and permissions, electronic signatures, version control, search, and audit trails. It also ensures continuous monitoring and data preservation for security and regulatory compliance.
- Multi-Lingual Open Environment: Supports third-party programming languages and tools, allowing data integration from various sources such as electronic data capture systems, in-house clinical data management systems, labs, and contract research organizations.
- Enhanced Efficiency: Utilizes SAS Viya-enabled solutions and technology, proven to be 30 times faster than commercial and open-source alternatives, improving efficiency and expediting the path to submission.
“SAS Clinical Acceleration Repository enables researchers and data scientists to better manage their clinical data and empowers organizations to make informed business decisions,” said Gail Stephens, Vice President of Healthcare and Life Sciences at SAS. “Accelerating and improving the clinical development process helps bring therapies to market sooner and strengthens the bottom line for life sciences and health organizations.”
Generating Synthetic Data to Bridge Real-World Data Gaps
To address data privacy and scarcity challenges, SAS has introduced SAS Data Maker, currently in private preview. This powerful tool generates synthetic tabular data that statistically represents original training data without compromising sensitive patient health information. This enables healthcare and life sciences companies to innovate faster by combining trusted data augmentation and generation algorithms in one seamless tool.
“SAS Data Maker uses SAS’ cutting-edge, reliable AI models to create statistically accurate data points that truly augment existing data and can capture countless different scenarios, helping organizations better forecast outcomes so they can anticipate their businesses’ changing needs,” said Shadi Shahin, Vice President of Product Strategy at SAS.
AstraZeneca, a global biopharmaceutical company, plans to use SAS Data Maker on the Snowflake Marketplace to empower its data scientists with synthetic data, enhancing decision-making processes.
“Synthetic data can enhance our ability to make informed decisions from critical data, and thus has the real potential to help accelerate drug discovery and development, ultimately benefiting patients around the world,” noted Brian Dummann, Chief Data Officer at AstraZeneca. “We look forward to leveraging SAS Data Maker and streamlining how data scientists can access synthetic data for their initiatives.”
Boosting Industry Solutions with AI
These new healthcare and life sciences products are part of SAS’ $1 billion commitment to AI-powered industry solutions over three years. This investment builds on SAS’ decades-long focus on providing tailored solutions to industry challenges in banking, government, insurance, healthcare, and more.
Learn more about how SAS transforms data into life-changing insights and accelerates breakthroughs in life sciences and healthcare here.
